XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes In Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Unallocated Common Stock Held by the Employee Stock Ownership Plan
Unallocated Common Stock Held by the Employee Stock Ownership Plan
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (loss) Net of tax
Accumulated Other Comprehensive Income (loss) Net of tax
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balance, Common Stock (in shares) at Dec. 31, 2020       52,209,897 52,209,897                      
Beginning Balance at Dec. 31, 2020 $ 753,981 $ (3,087) $ 750,894 $ 648 $ 648 $ 590,506 $ 590,506 $ (18,529) $ (18,529) $ 338,093 $ (3,087) $ 335,006 $ 13,160 $ 13,160 $ (169,897) $ (169,897)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 38,471                 38,471            
Other comprehensive loss, net of tax (2,705)                       (2,705)      
ESOP shares allocated or committed to be released 903         414   489                
Stock compensation expense 504         504                    
Restricted stock issuance (in shares)       147,315                        
Restricted stock issuance 0         (1,821)                 1,821  
Restricted stock forfeitures (in shares)       (3,237)                        
Restricted stock forfeitures 0         48                 (48)  
Exercise of stock options, net (in shares)       132,770                        
Exercise of stock options, net 1,815         13                 1,802  
Cash dividends declared and paid (11,839)                 (11,839)            
Repurchase of treasury stock (in shares)       (1,643,094)                        
Repurchase of treasury stock (24,833)                           (24,833)  
Ending Balance, Common Stock (in shares) at Jun. 30, 2021       50,843,651                        
Ending Balance at Jun. 30, 2021 753,210     $ 648   589,664   (18,040)   361,638     10,455   (191,155)  
Beginning Balance, Common Stock (in shares) at Mar. 31, 2021       51,668,197                        
Beginning Balance at Mar. 31, 2021 754,565     $ 648   589,188   (18,286)   348,236     12,267   (177,488)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 19,794                 19,794            
Other comprehensive loss, net of tax (1,812)                       (1,812)      
ESOP shares allocated or committed to be released 491         245   246                
Stock compensation expense 260         260                    
Restricted stock forfeitures (in shares)       (1,555)                        
Restricted stock forfeitures 0         22                 (22)  
Exercise of stock options, net (in shares)       77,780                        
Exercise of stock options, net 1,007         (51)                 1,058  
Cash dividends declared and paid (6,392)                 (6,392)            
Repurchase of treasury stock (in shares)       (900,771)                        
Repurchase of treasury stock (14,703)                           (14,703)  
Ending Balance, Common Stock (in shares) at Jun. 30, 2021       50,843,651                        
Ending Balance at Jun. 30, 2021 $ 753,210     $ 648   589,664   (18,040)   361,638     10,455   (191,155)  
Beginning Balance, Common Stock (in shares) at Dec. 31, 2021 49,266,733     49,266,733                        
Beginning Balance at Dec. 31, 2021 $ 739,883     $ 648   589,972   (17,058)   381,361     2,063   (217,103)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 30,001                 30,001            
Other comprehensive loss, net of tax (33,329)                       (33,329)      
ESOP shares allocated or committed to be released 852         378   474                
Stock compensation expense 845         845                    
Restricted stock issuance (in shares)       157,416                        
Restricted stock issuance 0         (2,484)                 2,484  
Restricted stock forfeitures (in shares)       (16,613)                        
Restricted stock forfeitures $ 0         237                 (237)  
Exercise of stock options, net (in shares) 17,040     17,040                        
Exercise of stock options, net $ 231         (8)                 239  
Cash dividends declared and paid (12,231)                 (12,231)            
Repurchase of treasury stock (in shares)       (739,701)                        
Repurchase of treasury stock $ (10,979)                           (10,979)  
Ending Balance, Common Stock (in shares) at Jun. 30, 2022 48,684,875     48,684,875                        
Ending Balance at Jun. 30, 2022 $ 715,273     $ 648   588,940   (16,584)   399,131     (31,266)   (225,596)  
Beginning Balance, Common Stock (in shares) at Mar. 31, 2022       48,910,192                        
Beginning Balance at Mar. 31, 2022 715,398     $ 648   588,131   (16,822)   389,387     (23,289)   (222,657)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 15,874                 15,874            
Other comprehensive loss, net of tax (7,977)                       (7,977)      
ESOP shares allocated or committed to be released 401         163   238                
Stock compensation expense 449         449                    
Restricted stock forfeitures (in shares)       (13,738)                        
Restricted stock forfeitures 0         197                 (197)  
Exercise of stock options, net (in shares)                              
Exercise of stock options, net 0                          
Cash dividends declared and paid (6,130)                 (6,130)            
Repurchase of treasury stock (in shares)       (211,579)                        
Repurchase of treasury stock $ (2,742)                           (2,742)  
Ending Balance, Common Stock (in shares) at Jun. 30, 2022 48,684,875     48,684,875                        
Ending Balance at Jun. 30, 2022 $ 715,273     $ 648   $ 588,940   $ (16,584)   $ 399,131     $ (31,266)   $ (225,596)